BIBW2992 (Afatinib)
A10141-5
5mg
Brand
AdooQ BioScience
Description
BIBW2992 (Afatinib) is tyrosine kinase inhibitor (TKI) that irreversibly inhibits human epidermal growth factor receptor 2 (Her2) and epidermal growth factor receptor (EGFR) kinases.
Targets
|
EGFR (L858R) (Cell-free assay) |
EGFR (wt) (Cell-free assay) |
EGFR (L858R/T790M) (Cell-free assay) |
HER2 (Cell-free assay) |
|
0.4 nM |
0.5 nM |
10 nM |
14 nM |
|
In vitro (25°C) |
DMSO |
97 mg/mL (199.61 mM) |
|
|
Water |
<1 mg/mL (<1 mM) |
|
|
Ethanol |
15 mg/mL (30.86 mM) |
|
In vivo |
0.5% methylcellulose/0.2% Tween 80 |
30 mg/mL |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|
|
|
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
|
0.1 mM |
20.58 mL |
102.9 mL |
205.8 mL |
|
0.5 mM |
4.12 mL |
20.58 mL |
41.16 mL |
|
1 mM |
2.06 mL |
10.29 mL |
20.58 mL |
|
5 mM |
0.41 mL |
2.06 mL |
4.12 mL |
*The above data is based on the productmolecular weight 485.9. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|
CATALOG NUM |
A10141 |
|
ACTIONS |
Inhibitor |
|
M. WT |
485.9 |
|
FORMULA |
C24H25ClFN5O3 |
|
SOLUBILITY |
DMSO |
|
PURITY |
>98% |
|
STORAGE |
at -20°C 3 years Powder |
|
CAS NO. |
439081-18-2 |
|
SYNONYMS |
Tomtovok,Afatinib |
|
SMILES |
CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4 |
Application
Reactivity
